Dao Tun GmbH welcomes Dr. Ulf Grawunder as new Advisor to the Team 

Basel (Switzerland), January 31, 2022  

Dao Tun GmbH, a Swiss advisory consulting company in the healthcare and life sciences field with a focus on Europe and China, welcomes Dr. Ulf Grawunder as new Advisor. 

“We are delighted that Dr. Ulf Grawunder joins the Dao Tun team in an advisory role and we look very much forward to the collaboration. Ulf’s profound knowledge and expertise in Life sciences and as a successful Biotech entrepreneur, as well as his ideas and perspectives are unmatched. Our clients will greatly benefit from his profound experience through the services we provide”, said Managing Partners Tianke Wang and Gabriele Matthias. 

Dr. Ulf Grawunder added “I am enthusiastic to join the Dao Tun team as a new Advisor and to support Dao Tun in providing their outstanding services and advancing their clients’ projects.

About Ulf Grawunder, PhD

Ulf Grawunder is Managing Partner of Viopas Venture Consulting (Basel, Switzerland), a consulting company in the healthcare sector supporting investors/family offices for investment opportunities and healthcare companies for fundraising, business strategy, licensing, and M&A respectively.

As a serial entrepreneur, Ulf Grawunder has founded several highly successful Biotech companies. In 2004, he co-founded the Biotech company 4-Antibody AG in Basel, Switzerland, and served as its founding CEO and later as CSO. 4-Antibody was sold in 2014 to Agenus Inc. Already in 2012 Ulf founded NBE-Therapeutics in Basel, Switzerland, developing next-generation antibody-drug conjugates (ADCs) for improved cancer therapies. He served as the company’s CEO since its foundation, as well as COO and CDO once the company started clinical trials and until Boehringer Ingelheim Inc. acquired NBE Therapeutics for USD 1.4 billion in 2021. Ulf also co-founded T-CURX in 2018, a spin-off from the University of Würzburg, Germany, focused on the development of CAR-T cell-based cancer therapies.

In addition, Ulf is an advisor, mentor and teacher in the Integrated Immunology Master’s program «iImmune» (University of Erlangen, Germany), the European Center for Pharmaceutical Medicine EPCM (University of Basel, Switzerland) and the Swiss Startup program «Venture Kick». Ulf also holds the roles of Vice-president and Board member in the Swiss Biotech Association.

Ulf is a biochemist and received his PhD in Immunology from the Basel Institute for Immunology (Switzerland). Before becoming a Biotech entrepreneur his academic career included positions as post-doctoral research scientist at Washington University School of Medicine (St. Louis, USA), the University of Southern California (Los Angeles, USA) and as principal investigator at the Basel Institute for Immunology and the University of Basel, Switzerland.

Ulf also has a Diploma in Technology Entrepreneurship from the University of St. Gallen School of Business, Switzerland. 

About Dao Tun GmbH

Dao Tun is offering consulting services on strategy, operations, business development, cross-border cooperation, market access, product distribution, in-/out-licensing, investment/fundraising, joint venture, M&A, in the healthcare/ Life sciences industry, with a focus on Europe and China.  Dao Tun’s European and Chinese clients (from start-ups to established companies) look for new opportunities to develop business relations and to grow their businesses. 


Tianke Wang, PhD

Founder/CEO, Managing partner (

Gabriele Y. Matthias, MSc, SCPM

Co-founder/ COO, Managing partner (